Navigation Links
Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
Date:11/3/2008

Ophthalmic Consultants of Boston points out that the use of anti-VEGF therapy in the treatment of patients with wet macular degeneration has revolutionized outcomes in this disease. However, in light of the work of Dr. D'Amore and others, in elucidating possible systemic and ocular side effects of these drugs, "caution must be exercised in identifying patients at increased risk of problems with long-term VEGF blockade, and potential side effects must be detected early in the assessment of patients who will require repeated dosages of anti-VEGF agents."

The study is also relevant to the drug Avastin, which was initially approved for intravenous use as an anti-angiogenic agent in the treatment of cancer, but is also widely used intravitreally for the treatment of wet AMD because of its similar mode of action and much lower cost.

The next steps in D'Amore's research will include investigating the specific functions of VEGF in the eye.

Authors of the study include: Magali Saint-Geniez (1,2), Arindel S. R. Maharaj (1), Tony E. Walshe (1,2), Budd A. Tucker (1,2), Eiichi Sekiyama (1,2), Tomoki Kurihara (1), Diane C. Darland (4), Michael J. Young (1,2), Patricia A. D'Amore (1,2,3)

(1) Schepens Eye Research Institute

(2) Department of Ophthalmology, Harvard Medical School

(3) Department of Pathology, Harvard Medical School

(4) University of North Dakota, Grand Forks, North Dakota

Schepens Eye Research Institute is an affiliate of Harvard Medical School and is the largest independent eye research institute in the nation.


'/>"/>
SOURCE Schepens Eye Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Tweens and teens double use of diabetes drugs
2. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
3. Tests Could Predict Benefit From Cancer Drugs
4. Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known
5. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
6. Common Heart Drugs May Hamper Blood Thinner
7. The Market for Disease-Modifying Osteoarthritis Drugs Will Experience Exponential Growth, Increasing From $477 Million in 2007 to Nearly $3.8 Billion in 2017
8. Albertsons LLC Launches $4.99 Prescription Discount Program Covering Over 500 Generic Drugs
9. Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
10. Cholesterol Drugs May Raise Post-Op Delirium Risk
11. First generation antipsychotic drugs as effective as newer ones in some children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... By Alan Mozes ... -- Pediatricians, take note: Many American parents are aware of ... to choose a pediatrician for their children, according to a ... from more than 1,600 parents -- further suggest that negative ... if that doctor has been recommended by a neighbor. ...
(Date:9/22/2014)... partner in the Global STEM Alliance, a new high-tech ... science, technology, engineering and math (STEM) around the world. ... (NYAS), Malaysian Prime Minister Najib Razak participated in the ... the goal of developing over 1,000,000 aspiring STEM leaders ... will create a host of learning opportunities, including student ...
(Date:9/22/2014)... 22, 2014 An inventor and anesthesiologist ... the problem of side-sleeping. "My lower arm always became ... designed a solution to this problem," she said. "It’s ... to have your arm 'fall asleep.'" , The Sleeping ... her side more comfortably. It avoids pain and restlessness ...
(Date:9/22/2014)... Quincy Bioscience, one of the fastest-growing ... National Self-Improvement Month this September. The Wisconsin-based ... access to self-improvement resources, especially for maintaining healthy ... products that preserve health is growing as Americans ... six years, Quincy Bioscience has been promoting the ...
(Date:9/22/2014)... The Workgroup for Electronic ... authority on the use of health IT to ... from its recent industry survey on the use ... electronic transactions adopted under the Health Insurance Portability ... from August 20 to September 5, which included ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3
... can be predicted with the use of diffusion-weighted MRI ... at New York University Medical Center in New York, ... chronic hepatitis in the United States, particularly hepatitis C, ... replace or supplement liver biopsy, which is relatively invasive ...
... Allscripts (Nasdaq: MDRX ),the leading provider of ... to improve healthcare, announced today that,it will report ... ended September,30, 2007 after the stock market closes ... Standard Time on the same day, Allscripts management ...
... Oct. 23 After five,successful years of steady ... today that it is celebrating five years of,continued ... sales growth,that indicates reaching 100,000 orders by the ... ), "Our ReBuilder for Diabetic Peripheral Neuropathy ...
... YORK, October 23 Answers.com(TM) (NASDAQ:,ANSW) ... interactive health education,videos from HealthiNation, a ... health content on Answers.com. (See example ... to consumers in categories such as ...
... more information, more, expertise and more options in their ... Oct. 23 As more than 7,000 leaders and,providers ... Meeting and Exposition,of the American Association of Homes and ... in Orlando, Florida, to explore the future of aging,services, ...
... between parents ... and teens, INDIANAPOLIS, ... at preventing drunk driving and,underage drinking with new 30-second radio public service ... timed to,coincide with the busy fall season and will air 2,300 times ...
Cached Medicine News:Health News:MRI predicts liver fibrosis, study says 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 3Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 2Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 3Health News:Answers.com Adds HealthiNation Video Content to Answer Engine(TM) 2Health News:'Will You Still Love Me, Will You Still Need Me, When I'm 84?' 2Health News:Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign 2
(Date:9/22/2014)... , Sept. 22, 2014  Aethlon Medical, Inc. ... devices to address infectious disease, cancer and other ... Research Projects Agency (DARPA) has informed the Company ... proceed with year four of a five-year $5.9 ... September 30, 2011 under DARPA,s Dialysis-Like Therapeutics (DLT) ...
(Date:9/22/2014)... , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... quarter and fiscal 2014 ended July 31, 2014 on Monday, ... call to discuss the results at 11:00 AM ET. Participating ... Chairman; Andrew A. Krakauer , President and CEO; ... Craig A. Sheldon , Senior Vice President, CFO and Treasurer; ...
(Date:9/22/2014)... SAN FRANCISCO , Sept. 22, 2014  Sutro ... FierceBiotech as one of 2014,s Fierce 15 ... promising private biotechnology companies in the industry.  ... A-list group of backers as well as industry partners ... developing antibody-drug conjugates and bispecifics," says John Carroll ...
Breaking Medicine Technology:Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... March 22 Cambrex Corporation (NYSE: ... a privately held company that is a leader in ... Wiesbaden, Germany and offers cost effective customized ... pharmaceutical industry, with the ability to utilize its tool ...
... Inc. (OTC Bulletin Board: GOVX), a biotechnology company that is developing and testing innovative HIV/AIDS vaccines, has engaged The Investor Relations Group ("IRG"), ... , ... , ... ...
Cached Medicine Technology:Cambrex Acquires IEP GmbH 2Cambrex Acquires IEP GmbH 3GeoVax Labs Engages The Investor Relations Group 2GeoVax Labs Engages The Investor Relations Group 3GeoVax Labs Engages The Investor Relations Group 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: